Predicting outcome from post-transplant lymphoproliferative disease: A risky business

被引：5

作者：

Green, M

Michaels, M

Webber, S

机构：

[1] Childrens Hosp Pittsburgh, Div Allerg Immunol & Infect Dis, Pittsburgh, PA 15213 USA

[2] Univ Pittsburgh, Sch Med, Dept Pediat & Surg, Pittsburgh, PA USA

来源：

PEDIATRIC TRANSPLANTATION | 2001年 / 5卷 / 04期

关键词：

D O I：

10.1034/j.1399-3046.2001.005004235.x

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：235 / 238

页数：4

共 15 条

[1] Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy [J].

Cacciarelli, TV ;

Green, M ;

Jaffe, R ;

Mazariegos, GV ;

Jain, A ;

Fung, JJ ;

Reyes, J .

TRANSPLANTATION, 1998, 66 (08) :1047-1052

[2] Post-transplant lymphoproliferative disease in children [J].

Collins, MH ;

Montone, KT ;

Leahey, AM ;

Hodinka, RL ;

Salhany, KE ;

Kramer, DL ;

Deng, C ;

Tomaszewski, JR .

PEDIATRIC TRANSPLANTATION, 2001, 5 (04) :250-257

[3] Lymphoproliferative disorders after organ transplantation in children [J].

Dror, Y ;

Greenberg, M ;

Taylor, G ;

Superina, R ;

Hébert, D ;

West, L ;

Connolly, B ;

Sena, L ;

Allen, U ;

Weitzman, S .

TRANSPLANTATION, 1999, 67 (07) :990-998

[4] Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression [J].

Ellis, D ;

Jaffe, R ;

Green, M ;

Janosky, JJ ;

Lombardozzi-Lane, S ;

Shapiro, R ;

Scantlebury, V ;

Vivas, C ;

Jordan, ML .

TRANSPLANTATION, 1999, 68 (07) :997-1003

[5]

Green M, 1999, Pediatr Transplant, V3, P271, DOI 10.1034/j.1399-3046.1999.00066.x

[6]

GREEN M, 1999, CURR OPIN ORGAN TRAN, V4, P292

[7] B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome [J].

Gross, TG ;

Steinbuch, M ;

DeFor, T ;

Shapiro, RS ;

McGlave, P ;

Ramsay, NKC ;

Wagner, JE ;

Filipovich, AH .

BONE MARROW TRANSPLANTATION, 1999, 23 (03) :251-258

[8] The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation [J].

Haque, T ;

Crawford, DH .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) :309-316

[9] Adoptive cellular immunotherapy for EBV lymphoproliferative diseases [J].

Heslop, HE ;

Rooney, CM .

IMMUNOLOGICAL REVIEWS, 1997, 157 :217-222

[10] Posttransplant lymphoproliferative disease in pediatric liver transplantation - Interplay between primary Epstein-Barr virus infection and immunosuppresion [J].

Newell, KA ;

Alonso, EM ;

Whitington, PF ;

Bruce, DS ;

Millis, JM ;

Piper, JB ;

Woodle, ES ;

Kelly, SM ;

Koeppen, H ;

Hart, J ;

Rubin, CM ;

Thistlethwaite, JR .

TRANSPLANTATION, 1996, 62 (03) :370-375

← 1 2 →